MANILA, Philippines — The Department of Science and Technology (DOST) is aiming to start the clinical trial on the mixing of different brands of COVID-19 vaccines by next month, an official said Thursday.
DOST Undersecretary Rowena Guevarra said the agency will focus on its application for a clearance from the Food and Drug Administration and getting a clearance from the Ethics Review Board.
She said the trial will involve 3,000 participants aged 18 and above. Five COVID-19 vaccine brands will be used, namely Sinovac, AstraZeneca, Pfizer, Moderna, and Sputnik V.
Twelve experiments will be done during the trial, with 250 participants each.
Participants in the t…
Keep on reading: DOST eyes start of COVID-19 mixed vaccine clinical trial by July